Suppr超能文献

空中救护车转运时间与急性 ST 段抬高型心肌梗死患者院间转运中实施的高级心脏生命支持干预。

Air ambulance transport times and advanced cardiac life support interventions during the interfacility transfer of patients with acute ST-segment elevation myocardial infarction.

机构信息

Department of Surgery, Division of Emergency Medicine, and the Air Medical Research Institute, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.

出版信息

Prehosp Emerg Care. 2010 Jul-Sep;14(3):292-9. doi: 10.3109/10903121003760192.

Abstract

OBJECTIVES

To characterize transport times for the interfacility air ambulance transport of patients with acute ST-segment elevation myocardial infarction (STEMI), to estimate the proportion of patients at risk of in-transport clinical decompensation, and to explore associated risk factors for such.

METHODS

The electronic medical records of 35 air ambulance programs in the United States from December 2003 through December 2008 were reviewed. We defined clinical decompensation during transport as the combined outcome of either cardiopulmonary arrest or the receipt of any of a prespecified set of advanced life support (ALS) interventions. Multiple logistic regression employing generalized estimating equations to model autocorrelation of measures within air ambulance programs was used to explore the relationship between time from dispatch to transport and the outcome of interest.

RESULTS

Three thousand seven hundred sixty-seven transports of STEMI patients were identified during the period of interest. Eighty-five percent of rotor wing transports (median 80 minutes, interquartile range [IQR] 66-104) and 7% of fixed-wing transports (median 162 minutes, IQR 142-210) attained a total transfer time of < or = 2 hours. Clinical decompensation in transport occurred in 182 of 3,767 (4.8%, 95% confidence interval [CI] 4.2-5.6%) transports. The most frequent critical ALS interventions were the administration of antiarrhythmics and the initiation of vasopressors. The odds ratios (ORs) for clinical decompensation comparing higher pretransport time quartiles with the lowest quartile (i.e., Q1: 6-50 minutes) were as follows: Q4: 82-1,500 minutes, OR 2.5 (95% CI 1.3-4.8, p = 0.007); Q3: 64-81 minutes, OR 1.9 (95% CI 1.0-3.6, p = 0.0499); and Q2: 51-63 minutes, OR 1.45 (95% CI 0.7-3.1, p = 0.34). Cardiac arrest or need for an ALS intervention prior to transport and a history of diabetes were also predictive of the outcome of interest.

CONCLUSIONS

The majority of interfacility rotor-wing air ambulance transfers of patients with STEMI achieved a total transfer time of < or = 2 hours. Clinical decompensation requiring ALS treatment occurred in a small percentage of patients. Diabetes, prior arrest or decompensation, and delays to transport were associated with clinical decompensation in the air. Efforts to reduce delays to transport may reduce this risk in transported patients.

摘要

目的

描述急症 ST 段抬高型心肌梗死(STEMI)患者院际空中救护车转运的转运时间,评估有发生转运中临床失代偿风险的患者比例,并探讨其相关危险因素。

方法

回顾了 2003 年 12 月至 2008 年 12 月期间美国 35 个空中救护项目的电子病历。我们将转运过程中的临床失代偿定义为心肺骤停或接受预先指定的一组高级生命支持(ALS)干预措施中的任何一项的综合结果。采用广义估计方程的多变量逻辑回归模型来模拟在空勤救护计划中措施的自相关,以探讨从派遣到转运的时间与研究结果之间的关系。

结果

在研究期间共确定了 3767 例 STEMI 患者的转运。85%的直升机转运(中位数 80 分钟,四分位距[IQR] 66-104)和 7%的固定翼转运(中位数 162 分钟,IQR 142-210)达到了<或=2 小时的总转运时间。3767 次转运中有 182 次(4.8%,95%置信区间[CI] 4.2-5.6%)发生了转运中临床失代偿。最常见的危急 ALS 干预措施是抗心律失常药物的使用和血管加压素的启动。与最低四分位组(即 Q1:6-50 分钟)相比,前转运时间四分位组(即 Q4:82-1500 分钟)发生临床失代偿的比值比(OR)为 2.5(95%CI 1.3-4.8,p=0.007);Q3:64-81 分钟,OR 1.9(95%CI 1.0-3.6,p=0.0499);Q2:51-63 分钟,OR 1.45(95%CI 0.7-3.1,p=0.34)。转运前发生心脏骤停或需要 ALS 干预以及有糖尿病史也是该研究结果的预测因素。

结论

大多数急症 STEMI 患者的院际直升机空中救护车转运总转运时间<或=2 小时。需要 ALS 治疗的临床失代偿在少数患者中发生。糖尿病、转运前的心脏骤停或失代偿以及转运延迟与空中发生的临床失代偿有关。减少转运延迟的努力可能会降低转运患者的这种风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验